| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.03 |